Hatteras Investment Partners’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q1
Sell
-2,355
Closed -$288K 30
2016
Q4
$288K Sell
2,355
-800
-25% -$97.8K 1.68% 28
2016
Q3
$387K Buy
+3,155
New +$387K 1.33% 30
2015
Q2
Sell
-8,659
Closed -$1.5M 141
2015
Q1
$1.5M Buy
+8,659
New +$1.5M 0.8% 45